Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis, chemical and biochemical characterization of Lu2O3-iPSMA nanoparticles activated by neutron irradiation.
Ancira-Cortez A, Ferro-Flores G, Jiménez-Mancilla N, Morales-Avila E, Trujillo-Benítez D, Ocampo-García B, Santos-Cuevas C, Escudero-Castellanos A, Luna-Gutiérrez M. Ancira-Cortez A, et al. Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111335. doi: 10.1016/j.msec.2020.111335. Epub 2020 Aug 7. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32919684
Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image.
Luna-Gutiérrez M, Ocampo-García B, Jiménez-Mancilla N, Ancira-Cortez A, Trujillo-Benítez D, Hernández-Jiménez T, Ramírez-Nava G, Hernández-Ramírez R, Santos-Cuevas C, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: ancira cortez a. Pharmaceutics. 2022 Mar 27;14(4):720. doi: 10.3390/pharmaceutics14040720. Pharmaceutics. 2022. PMID: 35456554 Free PMC article.
Synthesis and Biochemical Evaluation of Samarium-153 Oxide Nanoparticles Functionalized with iPSMA-Bombesin Heterodimeric Peptide.
Trujillo-Benítez D, Ferro-Flores G, Morales-Avila E, Jiménez-Mancilla N, Ancira-Cortez A, Ocampo-García B, Santos-Cuevas C, Escudero-Castellanos A, Luna-Gutiérrez M, Azorín-Vega E. Trujillo-Benítez D, et al. Among authors: ancira cortez a. J Biomed Nanotechnol. 2020 May 1;16(5):689-701. doi: 10.1166/jbn.2020.2924. J Biomed Nanotechnol. 2020. PMID: 32919488
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.
Luna-Gutiérrez M, Hernández-Ramírez R, Soto-Abundiz A, García-Pérez O, Ancira-Cortez A, López-Buenrostro S, Gibbens-Bandala B, Soldevilla-Gallardo I, Lara-Almazán N, Rojas-Pérez M, Ocampo-García B, Azorín-Vega E, Santos-Cuevas C, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: ancira cortez a. Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988. Pharmaceutics. 2023. PMID: 37514174 Free PMC article.
Toxicity Assessment of [177Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes.
Hernández-Jiménez T, Cruz-Nova P, Ancira-Cortez A, Gibbens-Bandala B, Lara-Almazán N, Ocampo-García B, Santos-Cuevas C, Morales-Avila E, Ferro-Flores G. Hernández-Jiménez T, et al. Among authors: ancira cortez a. Nanomaterials (Basel). 2022 Nov 25;12(23):4181. doi: 10.3390/nano12234181. Nanomaterials (Basel). 2022. PMID: 36500804 Free PMC article.